Physician profile
Michael D Abril
NPI 1245854728
$2,590.70
in general payments reported to CMS, 2019-2025
17 companies · $86.82 in 2025
The $86.82 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $34.43 · 2023: $2,440 · 2024: $29.00 · 2025: $86.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,456 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,456.28 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $537.55 | 2023-2024 | Rinvoq, Skyrizi, Botox |
| Janssen Biotech, INC. | $434.11 | 2023 | Tremfya |
| Incyte Corporation | $306.88 | 2022-2023 | Opzelura |
| Sun Pharmaceutical Industries INC. | $280.44 | 2023 | Winlevi, Absorica Ld, Levulan Kerastick |
| Regeneron Healthcare Solutions, INC. | $168.20 | 2023 | Dupixent, Libtayo |
| Pfizer INC. | $149.84 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $146.77 | 2023 | Arazlo, Jublia |
| Galderma Laboratories, L.P. | $138.22 | 2023 | Aklief |
| Dermavant Sciences, INC. | $127.04 | 2023 | Vtama |
| Revance Therapeutics, INC. | $86.82 | 2025 | Daxxify |
| Lilly USA, LLC | $51.72 | 2022-2024 | Olumiant, Taltz |
| E.R. Squibb & Sons, L.L.C. | $38.85 | 2023 | Sotyktu |
| Argenx US, INC. | $33.62 | 2023 | Vyvgart Hytrulo |
| Amgen INC. | $32.80 | 2023 | Otezla |
| Mayne Pharma Commercial LLC | $22.52 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $18.04 | 2023 | |
| Arcutis Biotherapeutics, INC. | $17.28 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Abril listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.